UBS Assumes Myriad Genetics (MYGN) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 6.02 -0.02 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.04 | 52 Week High | $45.34 | |||
| Open | $6.09 | 52 Week Low | $15.92 | |||
| Day High | $6.20 | P/E | 2.58 | |||
| Day Low | $5.90 | EPS | $2.33 | |||
| Volume | 2,112,519 | |||||
